Serina Therapeutics
NYSE: SERHuntsville, US · Alabama corporation · 1 known investors
Biotech
Founders & leadership
MA
Miguel A LoyaDirector
RW
Randall W MoreadithExecutive Officer, Director
JR
James R Hudson, Jr.Director
MD
Michael D BentleyExecutive Officer, Director
JM
J Milton HarrisExecutive Officer, Director
BF
Barbara FiskDirector
TV
Tacey ViegasExecutive Officer
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$10MraisedMar 2023 · 1 investors · BiotechnologyRule 506(b)
▶$10MraisedMar 2023 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Barbara M FiskDirector
- James R Hudson, Jr.Director
- Randall W MoreadithExecutive Officer, Director
- Steve LedgerDirector
- Greg H Bailey, M.D.Director
- J Milton HarrisExecutive Officer, Director
- Tacey ViegasExecutive Officer
- Michael D BentleyExecutive Officer, Director
- Offering amount
- $10M
- Amount sold
- $10M
- First sale
- Mar 2023
- Incorporated
- Corporation, Alabama
- Federal exemptions
- 06b
▶$3.6MraisedNov 2022 · 1 investors · BiotechnologyRule 506(b)
▶$3.6MraisedNov 2022 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Miguel A LoyaDirector
- Randall W MoreadithExecutive Officer, Director
- James R Hudson, Jr.Director
- Michael D BentleyExecutive Officer, Director
- J Milton HarrisExecutive Officer, Director
- Barbara FiskDirector
- Tacey ViegasExecutive Officer
- Offering amount
- $3.6M
- Amount sold
- $3.6M
- First sale
- Nov 2022
- Incorporated
- Corporation, Alabama
- Federal exemptions
- 06b
▶$1MraisedJul 2022 · 3 investors · BiotechnologyRule 506(b)
▶$1MraisedJul 2022 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Barbara FiskDirector
- Miguel A LoyaDirector
- James R Hudson, Jr.Director
- Randall W MoreadithExecutive Officer, Director
- Tacey ViegasExecutive Officer
- Michael D BentleyExecutive Officer, Director
- J Milton HarrisExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $1M
- First sale
- Jun 2022
- Incorporated
- Corporation, Alabama
- Federal exemptions
- 06b
▶$3.7MraisedJun 2021 · 12 investors · BiotechnologyRule 506(b)
▶$3.7MraisedJun 2021 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael D BentleyExecutive Officer, Director
- James R Hudson, Jr.Director
- Randall W MoreadithExecutive Officer, Director
- J Milton HarrisExecutive Officer, Director
- Barbara FiskDirector
- Miguel A LoyaDirector
- Tacey ViegasExecutive Officer
- Offering amount
- $76.2M
- Amount sold
- $3.7M
- First sale
- Jul 2019
- Incorporated
- Corporation, Alabama
- Federal exemptions
- 06b
▶$8.2MraisedApr 2018 · 18 investors · BiotechnologyRule 506(b)
▶$8.2MraisedApr 2018 · 18 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- James R Hudson, Jr.Director
- Michael D BentleyExecutive Officer, Director
- Barbara FiskDirector
- J Milton HarrisExecutive Officer, Director
- Miguel A LoyaDirector
- Tacey ViegasExecutive Officer
- Randall W MoreadithExecutive Officer, Director
- Brendan RaeExecutive Officer
- Offering amount
- $32.5M
- Amount sold
- $8.2M
- First sale
- Jan 2017
- Incorporated
- Corporation, Alabama
- Federal exemptions
- 06b
▶$4.9MraisedMar 2015 · 21 investors · BiotechnologyRule 506(b)
▶$4.9MraisedMar 2015 · 21 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Tacey ViegasExecutive Officer
- J Milton HarrisExecutive Officer, Director
- James R Hudson, Jr.Director
- Randall W MoreadithExecutive Officer, Director
- Barbara FiskDirector
- Michael D BentleyExecutive Officer, Director
- Offering amount
- $6.3M
- Amount sold
- $4.9M
- First sale
- Apr 2014
- Incorporated
- Corporation, Alabama
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.